u.s.
.jeffrey krasner is president of emerging biocommunications, which consults to early- and mid-stage life science companies.
.
we�re at the beginning of a new breakout level of truth. it�s called independent media.
.
in a news release, the drug's manufacturer, amgen, said the list price will be 5 a month or ,900 annually. costs to patients may vary depending on insurance.
.
u.s.
.jeffrey krasner is president of emerging biocommunications, which consults to early- and mid-stage life science companies.
.